Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin (Q46698290)

http://europepmc.org/abstract/MED/24032977

24 December 2017

title

Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin (English)

1 reference

http://europepmc.org/abstract/MED/24032977

24 December 2017

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Enrico Derenzini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Lisa Argnani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Cinzia Pellegrini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Monica Celli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Alessandro Broccoli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

30 August 2013

1 reference

http://europepmc.org/abstract/MED/24032977

24 December 2017

published in

British Journal of Haematology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

681-683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24032977%20AND%20SRC:MED&resulttype=core&format=json

Modern treatment of Hodgkin lymphoma.

13 June 2020

cites work

1 reference

Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma

21 January 2018

1 reference

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.

21 January 2018

1 reference

Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients

21 January 2018

1 reference

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.

21 January 2018

1 reference

Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

21 January 2018

1 reference

Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma

21 January 2018

1 reference

Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial

21 January 2018

1 reference